ALZN
Price
$1.00
Change
-$0.04 (-3.85%)
Updated
Mar 28, 6:59 PM EST
BEAM
Price
$33.04
Change
-$0.92 (-2.71%)
Updated
Mar 28, 6:59 PM EST
40 days until earnings call
Ad is loading...

Compare trend and price ALZN vs BEAM

Header iconALZN vs BEAM Comparison
Open Charts ALZN vs BEAMBanner chart's image
Alzamend Neuro
Price$1.00
Change-$0.04 (-3.85%)
Volume$11.58K
CapitalizationN/A
Beam Therapeutics
Price$33.04
Change-$0.92 (-2.71%)
Volume$736.61K
CapitalizationN/A
View a ticker or compare two or three
ALZN vs BEAM Comparison Chart

Loading...

ALZNDaily Signal changed days agoGain/Loss if shorted
 
Show more...
BEAMDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
ALZN vs. BEAM commentary
Mar 29, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALZN is a Hold and BEAM is a Hold.

COMPARISON
Comparison
Mar 29, 2024
Stock price -- (ALZN: $1.00 vs. BEAM: $33.04)
Brand notoriety: ALZN and BEAM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALZN: 21% vs. BEAM: 51%
Market capitalization -- ALZN: $6.75M vs. BEAM: $2.78B
ALZN [@Biotechnology] is valued at $6.75M. BEAM’s [@Biotechnology] market capitalization is $2.78B. The market cap for tickers in the [@Biotechnology] industry ranges from $576.05B to $0. The average market capitalization across the [@Biotechnology] industry is $2.64B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALZN’s FA Score shows that 0 FA rating(s) are green whileBEAM’s FA Score has 0 green FA rating(s).

  • ALZN’s FA Score: 0 green, 5 red.
  • BEAM’s FA Score: 0 green, 5 red.
According to our system of comparison, BEAM is a better buy in the long-term than ALZN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALZN’s TA Score shows that 5 TA indicator(s) are bullish while BEAM’s TA Score has 4 bullish TA indicator(s).

  • ALZN’s TA Score: 5 bullish, 4 bearish.
  • BEAM’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, ALZN is a better buy in the short-term than BEAM.

Price Growth

ALZN (@Biotechnology) experienced а -4.76% price change this week, while BEAM (@Biotechnology) price change was -5.46% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.78%. For the same industry, the average monthly price growth was +4.85%, and the average quarterly price growth was +88.40%.

Reported Earning Dates

ALZN is expected to report earnings on Jan 03, 2024.

BEAM is expected to report earnings on May 07, 2024.

Industries' Descriptions

@Biotechnology (+4.78% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for ALZN with price predictions.
OPEN
A.I.dvisor published
a Summary for BEAM with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
BEAM($2.78B) has a higher market cap than ALZN($6.75M). BEAM YTD gains are higher at: 21.381 vs. ALZN (12.360). ALZN has higher annual earnings (EBITDA): -15.33M vs. BEAM (-156.47M). BEAM has more cash in the bank: 1.19B vs. ALZN (1.7M). ALZN has less debt than BEAM: ALZN (345K) vs BEAM (173M). BEAM has higher revenues than ALZN: BEAM (378M) vs ALZN (0).
ALZNBEAMALZN / BEAM
Capitalization6.75M2.78B0%
EBITDA-15.33M-156.47M10%
Gain YTD12.36021.38158%
P/E RatioN/AN/A-
Revenue0378M-
Total Cash1.7M1.19B0%
Total Debt345K173M0%
TECHNICAL ANALYSIS
Technical Analysis
ALZNBEAM
RSI
ODDS (%)
Bearish Trend 1 day ago
80%
Bearish Trend 1 day ago
77%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
69%
Bullish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 1 day ago
84%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
81%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
85%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
76%
Bearish Trend 1 day ago
86%
Advances
ODDS (%)
Bullish Trend 7 days ago
82%
Bullish Trend 8 days ago
81%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 17 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
88%
Aroon
ODDS (%)
N/A
Bullish Trend 1 day ago
82%
View a ticker or compare two or three
Ad is loading...
ALZNDaily Signal changed days agoGain/Loss if shorted
 
Show more...
BEAMDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OPAL5.020.21
+4.37%
OPAL Fuels
GTBP4.450.08
+1.83%
GT Biopharma
LOGI89.370.91
+1.03%
Logitech International SA
AMK35.370.13
+0.37%
AssetMark Financial Holdings
PHAT10.62-0.45
-4.07%
Phathom Pharmaceuticals

ALZN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALZN has been loosely correlated with SNSE. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if ALZN jumps, then SNSE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALZN
1D Price
Change %
ALZN100%
-1.96%
SNSE - ALZN
41%
Loosely correlated
-3.67%
SPRC - ALZN
31%
Poorly correlated
+1.72%
AXON - ALZN
30%
Poorly correlated
-0.84%
MDGL - ALZN
29%
Poorly correlated
+3.18%
AVRO - ALZN
29%
Poorly correlated
+1.59%
More

BEAM and

Correlation & Price change

A.I.dvisor indicates that over the last year, BEAM has been closely correlated with NTLA. These tickers have moved in lockstep 77% of the time. This A.I.-generated data suggests there is a high statistical probability that if BEAM jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BEAM
1D Price
Change %
BEAM100%
-2.82%
NTLA - BEAM
77%
Closely correlated
+1.89%
DNLI - BEAM
68%
Closely correlated
-1.20%
VERV - BEAM
63%
Loosely correlated
+0.68%
EDIT - BEAM
63%
Loosely correlated
-0.20%
PRME - BEAM
62%
Loosely correlated
+3.40%
More